{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T13:42:29Z","timestamp":1779284549864,"version":"3.51.4"},"reference-count":125,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Pediatric macular disorders are a diverse group of inherited retinal diseases characterized by central vision loss due to dysfunction and degeneration of the macula, the region of the retina responsible for high-acuity vision. Common disorders in this category include Stargardt disease, Best vitelliform macular dystrophy, and X-linked retinoschisis. These conditions often manifest during childhood or adolescence, with symptoms such as progressive central vision loss, photophobia, and difficulty with fine visual tasks. Underlying mechanisms involve genetic mutations that disrupt photoreceptor and retinal pigment epithelium function, accumulating toxic byproducts, impaired ion channel activity, or structural degeneration. Advances in imaging modalities like optical coherence tomography and fundus autofluorescence have improved diagnostic accuracy and disease monitoring. Emerging therapies are transforming the treatment landscape. Gene therapy and genome editing hold promise for addressing the genetic basis of these disorders, while stem cell-based approaches and pharmacological interventions aim to restore retinal function and mitigate damage. Personalized medicine, driven by genomic sequencing, offers the potential for tailored interventions. Despite current challenges, ongoing research into molecular mechanisms, advanced imaging, and innovative therapies provides hope for improving outcomes and quality of life in children with macular disorders.<\/jats:p>","DOI":"10.3390\/jcm14020614","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T10:32:15Z","timestamp":1737369135000},"page":"614","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Advancing Insights into Pediatric Macular Diseases: A Comprehensive Review"],"prefix":"10.3390","volume":"14","author":[{"given":"Lucia","family":"Ambrosio","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, University of Naples Federico II, 80138 Naples, Italy"},{"name":"Department of Public Health, University of Naples Federico II, 80138 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Perepelkina","sequence":"additional","affiliation":[{"name":"Massachusetts Eye Associates, Chelmsford, MA 01824, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1412-375X","authenticated-orcid":false,"given":"Abdelrahman M.","family":"Elhusseiny","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Harvey and Bernice Jones Eye Institute, Little Rock, AR 72205, USA"},{"name":"Department of Ophthalmology, Boston Children\u2019s Hospital, Boston, MA 02115, USA"},{"name":"Department of Ophthalmology, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne B.","family":"Fulton","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Boston Children\u2019s Hospital, Boston, MA 02115, USA"},{"name":"Department of Ophthalmology, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Efren","family":"Gonzalez Monroy","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Boston Children\u2019s Hospital, Boston, MA 02115, USA"},{"name":"Department of Ophthalmology, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000357293","article-title":"Juvenile-onset macular degeneration and allied disorders","volume":"53","author":"North","year":"2014","journal-title":"Dev. Ophthalmol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"100327","DOI":"10.1016\/j.xops.2023.100327","article-title":"Multimodal Phenomap of Stargardt Disease Integrating Structural, Psychophysical, and Electrophysiologic Measures of Retinal Degeneration","volume":"4","author":"Abousy","year":"2024","journal-title":"Ophthalmol. Sci."},{"key":"ref_3","unstructured":"(2024, November 27). Pediatric Macular Disorders. Available online: https:\/\/www.aao.org\/education\/disease-review\/pedantic-macular-disorders."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-3-319-95046-4_27","article-title":"Stargardt Disease","volume":"1085","author":"Tsang","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1097\/IAE.0000000000001903","article-title":"Visual Acuity in Patients with Stargardt Disease After Age 40","volume":"38","author":"Collison","year":"2018","journal-title":"Retina"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1167\/tvst.10.4.24","article-title":"Automatic Segmentation in Multiple OCT Layers For Stargardt Disease Characterization Via Deep Learning","volume":"10","author":"Mishra","year":"2021","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/ceo.13947","article-title":"Stargardt disease: Multimodal imaging: A review","volume":"49","author":"Chen","year":"2021","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/ceo.13875","article-title":"Molecular diagnosis based on comprehensive genetic testing in 800 Chinese families with non-syndromic inherited retinal dystrophies","volume":"49","author":"Liu","year":"2021","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/humu.24064","article-title":"Genetic architecture of inherited retinal degeneration in Germany: A large cohort study from a single diagnostic center over a 9-year period","volume":"41","author":"Weisschuh","year":"2020","journal-title":"Hum. Mutat."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Jespersgaard, C., Fang, M., Bertelsen, M., Dang, X., Jensen, H., Chen, Y., Bech, N., Dai, L., Rosenberg, T., and Zhang, J. (2019). Molecular genetic analysis using targeted NGS analysis of 677 individuals with retinal dystrophy. Sci. Rep., 9.","DOI":"10.1038\/s41598-018-38007-2"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Areblom, M., Kjellstr\u00f6m, S., Andr\u00e9asson, S., \u00d6hberg, A., Gr\u00e4nse, L., and Kjellstr\u00f6m, U. (2023). A Description of the Yield of Genetic Reinvestigation in Patients with Inherited Retinal Dystrophies and Previous Inconclusive Genetic Testing. Genes, 14.","DOI":"10.3390\/genes14071413"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1167\/iovs.63.2.11","article-title":"Impact of Next Generation Sequencing in Unraveling the Genetics of 1036 Spanish Families With Inherited Macular Dystrophies","volume":"63","author":"Swafiri","year":"2022","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ajhg.2022.01.008","article-title":"Personalized genetic counseling for Stargardt disease: Offspring risk estimates based on variant severity","volume":"109","author":"Cornelis","year":"2022","journal-title":"Am. J. Hum. Genet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/bjophthalmol-2019-315086","article-title":"Macular dystrophies: Clinical and imaging features, molecular genetics and therapeutic options","volume":"104","author":"Rahman","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"101244","DOI":"10.1016\/j.preteyeres.2024.101244","article-title":"Phenotyping and genotyping inherited retinal diseases: Molecular genetics, clinical and imaging features, and therapeutics of macular dystrophies, cone and cone-rod dystrophies, rod-cone dystrophies, Leber congenital amaurosis, and cone dysfunction syndromes","volume":"100","author":"Georgiou","year":"2024","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ophtha.2014.08.032","article-title":"Early-onset stargardt disease: Phenotypic and genotypic characteristics","volume":"122","author":"Lambertus","year":"2015","journal-title":"Ophthalmology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/13816810802695550","article-title":"Natural history of phenotypic changes in Stargardt macular dystrophy","volume":"30","author":"Walia","year":"2009","journal-title":"Ophthalmic Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/IAE.0000000000000659","article-title":"Insights into Autosomal Dominant Stargardt-Like Macular Dystrophy Through Multimodality Diagnostic Imaging","volume":"36","author":"Palejwala","year":"2016","journal-title":"Retina"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/bjophthalmol-2016-308823","article-title":"Stargardt disease: Clinical features, molecular genetics, animal models and therapeutic options","volume":"101","author":"Tanna","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1076\/opge.24.2.75.13996","article-title":"The gene for Stargardt disease, ABCA4, is a major retinal gene: A mini-review","volume":"24","author":"Koenekoop","year":"2003","journal-title":"Ophthalmic Genet."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Dandona, L., and Dandona, R. (2006). Revision of visual impairment definitions in the International Statistical Classification of Diseases. BMC Med., 4.","DOI":"10.1186\/1741-7015-4-7"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.oret.2016.08.009","article-title":"Fixation Location and Stability Using the MP-1 Microperimeter in Stargardt Disease: ProgStar Report No. 3","volume":"1","author":"Ibrahim","year":"2017","journal-title":"Ophthalmol. Retina"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/archophthalmol.2011.332","article-title":"Centrifugal expansion of fundus autofluorescence patterns in Stargardt disease over time","volume":"130","author":"Cukras","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1001\/archopht.1976.03910040721003","article-title":"Fundus flavimaculatus. A clinical classification","volume":"94","author":"Fishman","year":"1976","journal-title":"Arch. Ophthalmol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/00006982-200412000-00013","article-title":"Electroretinographic findings in patients with Stargardt disease and fundus flavimaculatus","volume":"24","author":"Oh","year":"2004","journal-title":"Retina"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/archopht.119.3.359","article-title":"Phenotypic subtypes of Stargardt macular dystrophy-fundus flavimaculatus","volume":"119","author":"Lois","year":"2001","journal-title":"Arch. Ophthalmol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10633-022-09872-0","article-title":"ISCEV Standard for full-field clinical electroretinography (2022 update)","volume":"144","author":"Robson","year":"2022","journal-title":"Doc. Ophthalmol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/bjophthalmol-2020-317712","article-title":"Randomised study evaluating the pharmacodynamics of emixustat hydrochloride in subjects with macular atrophy secondary to Stargardt disease","volume":"106","author":"Kubota","year":"2022","journal-title":"Br. J. Ophthalmol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ajo.2022.02.013","article-title":"Three-Year Safety Results of SAR422459 (EIAV-ABCA4) Gene Therapy in Patients With ABCA4-Associated Stargardt Disease: An Open-Label Dose-Escalation Phase I\/IIa Clinical Trial, Cohorts 1-5","volume":"240","author":"Parker","year":"2022","journal-title":"Am. J. Ophthalmol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0140-6736(14)61376-3","article-title":"Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt\u2019s macular dystrophy: Follow-up of two open-label phase 1\/2 studies","volume":"385","author":"Schwartz","year":"2015","journal-title":"Lancet"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.ophtha.2018.04.037","article-title":"Transplantation of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells in Macular Degeneration","volume":"125","author":"Mehat","year":"2018","journal-title":"Ophthalmology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/bjophthalmol-2020-316225","article-title":"Long-term safety and tolerability of subretinal transplantation of embryonic stem cell-derived retinal pigment epithelium in Asian Stargardt disease patients","volume":"105","author":"Sung","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.preteyeres.2017.01.006","article-title":"Bestrophin 1 and retinal disease","volume":"58","author":"Johnson","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_34","first-page":"784","article-title":"Best vitelliform macular dystrophy: Literature review","volume":"9","author":"Budiene","year":"2014","journal-title":"Cent. Eur. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ajo.2012.02.036","article-title":"Frequency, genotype, and clinical spectrum of best vitelliform macular dystrophy: Data from a national center in Denmark","volume":"154","author":"Bitner","year":"2012","journal-title":"Am. J. Ophthalmol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/13816810.2016.1175645","article-title":"Vitelliform dystrophies: Prevalence in Olmsted County, Minnesota, United States","volume":"38","author":"Dalvin","year":"2017","journal-title":"Ophthalmic Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/aos.12142","article-title":"Best vitelliform macular dystrophy in a Swedish family: Genetic analysis and a seven-year follow-up of photodynamic treatment of a young boy with choroidal neovascularization","volume":"92","author":"Frennesson","year":"2014","journal-title":"Acta Ophthalmol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/IAE.0b013e31819d4fda","article-title":"Clinical and molecular genetic analysis of best vitelliform macular dystrophy","volume":"29","author":"Boon","year":"2009","journal-title":"Retina"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.preteyeres.2009.04.002","article-title":"The spectrum of ocular phenotypes caused by mutations in the BEST1 gene","volume":"28","author":"Boon","year":"2009","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Gao, T., Tian, C., Hu, Q., Liu, Z., Zou, J., Huang, L., and Zhao, M. (2018). Clinical and Mutation Analysis of Patients with Best Vitelliform Macular Dystrophy or Autosomal Recessive Bestrophinopathy in Chinese Population. Biomed. Res. Int., 2018.","DOI":"10.1155\/2018\/4582816"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1167\/iovs.06-0868","article-title":"Differential macular and peripheral expression of bestrophin in human eyes and its implication for best disease","volume":"48","author":"Mullins","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1167\/iovs.04-0550","article-title":"Mutations of VMD2 splicing regulators cause nanophthalmos and autosomal dominant vitreoretinochoroidopathy (ADVIRC)","volume":"45","author":"Yardley","year":"2004","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ajo.2005.09.018","article-title":"Evidence of genetic heterogeneity in MRCS (microcornea, rod-cone dystrophy, cataract, and posterior staphyloma) syndrome","volume":"141","author":"Michaelides","year":"2006","journal-title":"Am. J. Ophthalmol."},{"key":"ref_44","unstructured":"MacDonald, I.M., Lee, T., and Lawrence, J. (1993\u20132021). Bestrophinopathies. GeneReviews\u00ae [Internet], University of Washington."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/archopht.124.6.887","article-title":"Novel de novo mutation in a patient with Best macular dystrophy","volume":"124","author":"Apushkin","year":"2006","journal-title":"Arch. Ophthalmol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ophtha.2024.01.027","article-title":"Best Vitelliform Macular Dystrophy Natural History Study Report 1: Clinical Features and Genetic Findings","volume":"131","author":"Laich","year":"2024","journal-title":"Ophthalmology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0161-6420(93)31420-X","article-title":"Visual acuity in patients with best vitelliform macular dystrophy","volume":"100","author":"Fishman","year":"1993","journal-title":"Ophthalmology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/IAE.0b013e3181f441c1","article-title":"Preferential hyperacuity perimeter in best vitelliform macular dystrophy","volume":"31","author":"Querques","year":"2011","journal-title":"Retina"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/13816810.2011.567884","article-title":"Anterior segment abnormalities and angle-closure glaucoma in a family with a mutation in the BEST1 gene and Best vitelliform macular dystrophy","volume":"32","author":"Ponjavic","year":"2011","journal-title":"Ophthalmic Genet."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/S0140-6736(17)31469-1","article-title":"Glaucoma","volume":"390","author":"Jonas","year":"2017","journal-title":"Lancet"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1001\/archopht.1977.04450060070004","article-title":"Multifocal Best\u2019s vitelliform dystrophy","volume":"95","author":"Miller","year":"1977","journal-title":"Arch. Ophthalmol."},{"key":"ref_52","first-page":"2960","article-title":"Functional and clinical data of Best vitelliform macular dystrophy patients with mutations in the BEST1 gene","volume":"15","author":"Querques","year":"2009","journal-title":"Mol. Vis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40942-019-0156-0","article-title":"Best vitelliform macular dystrophy in a large Brazilian family","volume":"5","author":"Mello","year":"2019","journal-title":"Int. J. Retin. Vitr."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/archopht.1969.00990010307001","article-title":"Electro-oculography in families with vitelliform dystrophy of the fovea. Detection of the carrier state","volume":"81","author":"Deutman","year":"1969","journal-title":"Arch. Ophthalmol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0161-6420(81)34965-3","article-title":"Long-term evaluation of patients with Best\u2019s vitelliform dystrophy","volume":"88","author":"Mohler","year":"1981","journal-title":"Ophthalmology"},{"key":"ref_56","first-page":"304","article-title":"Heredodystrophic disorders affecting the pigment epithelium and retina","volume":"1","author":"Gass","year":"1997","journal-title":"Stereosc. Atlas Macular Dis. Diagn. Treat."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1442-9071.1991.tb00665.x","article-title":"Vitelliform dystrophy: Long-term observations on New Zealand pedigrees","volume":"19","author":"Clemett","year":"1991","journal-title":"Aust. N. Z. J. Ophthalmol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00006982-200112000-00003","article-title":"Visual outcome following subretinal hemorrhage in Best disease","volume":"21","author":"Chung","year":"2001","journal-title":"Retina"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Ong, S.S., Patel, T.P., and Singh, M.S. (2019). Optical Coherence Tomography Angiography Imaging in Inherited Retinal Diseases. J. Clin. Med., 8.","DOI":"10.3390\/jcm8122078"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/bjophthalmol-2017-310586","article-title":"Optical coherence tomography angiography characterisation of Best disease and associated choroidal neovascularisation","volume":"102","author":"Guduru","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s00417-007-0604-7","article-title":"Choroidal neovascularisation secondary to Best\u2019s disease in a 13-year-old boy treated by intravitreal bevacizumab","volume":"245","author":"Leu","year":"2007","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0002-9394(03)00711-6","article-title":"Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in best disease","volume":"136","author":"Andrade","year":"2003","journal-title":"Am. J. Ophthalmol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3928\/01913913-20120821-02","article-title":"An evidence-based review of vascular endothelial growth factor inhibition in pediatric retinal diseases: Part 2. Coats\u2019 disease, best disease, and uveitis with childhood neovascularization","volume":"50","author":"Chaudhary","year":"2013","journal-title":"J. Pediatr. Ophthalmol. Strabismus"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s004170000186","article-title":"Hereditary retinal dystrophies and choroidal neovascularization","volume":"238","author":"Marano","year":"2000","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"708","DOI":"10.4103\/ijo.IJO_1046_17","article-title":"Macular hole-associated retinal detachment in Best vitelliform dystrophy: Series of two cases and literature review","volume":"66","author":"Tewari","year":"2018","journal-title":"Indian. J. Ophthalmol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000501845","article-title":"Large, Spontaneous Macular Hole with Posterior Pole Detachment in a Patient with Best Vitelliform Macular Dystrophy","volume":"10","author":"Peart","year":"2019","journal-title":"Case Rep. Ophthalmol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/ICB.0000000000000068","article-title":"Best disease associated with macular hole","volume":"9","author":"Nourinia","year":"2015","journal-title":"Retin. Cases Brief. Rep."},{"key":"ref_68","unstructured":"Tripathy, K., and Salini, B. (2024, November 27). Best Disease, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK537290\/."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/ceo.12325","article-title":"Does levodopa improve vision in albinism? Results of a randomized, controlled clinical trial","volume":"42","author":"Summers","year":"2014","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/adc.80.6.565","article-title":"Oculocutaneous albinism","volume":"80","author":"Biswas","year":"1999","journal-title":"Arch. Dis. Child."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archophthalmol.2008.550","article-title":"Abnormal foveal morphology in ocular albinism imaged with spectral-domain optical coherence tomography","volume":"127","author":"Chong","year":"2009","journal-title":"Arch. Ophthalmol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1167\/iovs.64.15.30","article-title":"Nystagmus Characteristics in Albinism: Unveiling the Link to Foveal Hypoplasia and Visual Acuity","volume":"64","author":"Talsma","year":"2023","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3928\/01913913-20150427-06","article-title":"Clinical Insights Into Foveal Morphology in Albinism","volume":"52","author":"McCafferty","year":"2015","journal-title":"J. Pediatr. Ophthalmol. Strabismus"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/humu.22315","article-title":"DNA variations in oculocutaneous albinism: An updated mutation list and current outstanding issues in molecular diagnostics","volume":"34","author":"Simeonov","year":"2013","journal-title":"Hum. Mutat."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Kamaraj, B., and Purohit, R. (2014). Mutational analysis of oculocutaneous albinism: A compact review. Biomed. Res. Int., 2014.","DOI":"10.1155\/2014\/905472"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/pcmr.12167","article-title":"Increasing the complexity: New genes and new types of albinism","volume":"27","author":"Montoliu","year":"2014","journal-title":"Pigment. Cell Melanoma Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1750-1172-2-43","article-title":"Oculocutaneous albinism","volume":"2","author":"Ek","year":"2007","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_78","first-page":"240","article-title":"A novel GPR143 mutation in a Chinese family with X-linked ocular albinism type 1","volume":"21","author":"Gao","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0166-2236(96)10080-1","article-title":"The albino retina: An abnormality that provides insight into normal retinal development","volume":"20","author":"Jeffery","year":"1997","journal-title":"Trends Neurosci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"8921","DOI":"10.1523\/JNEUROSCI.23-26-08921.2003","article-title":"Organization of the visual cortex in human albinism","volume":"23","author":"Hoffmann","year":"2003","journal-title":"J. Neurosci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1523\/JNEUROSCI.5050-11.2012","article-title":"Eye-specific projections of retinogeniculate axons are altered in albino mice","volume":"32","author":"Rebsam","year":"2012","journal-title":"J. Neurosci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1749-8104-9-11","article-title":"Delayed neurogenesis leads to altered specification of ventrotemporal retinal ganglion cells in albino mice","volume":"9","author":"Bhansali","year":"2014","journal-title":"Neural Dev."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/ejn.14396","article-title":"Conversations with Ray Guillery on albinism: Linking Siamese cat visual pathway connectivity to mouse retinal development","volume":"49","author":"Mason","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.visres.2010.02.003","article-title":"Arrested development: High-resolution imaging of foveal morphology in albinism","volume":"50","author":"McAllister","year":"2010","journal-title":"Vision. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/archopht.1978.03910050173014","article-title":"Human albinism. Light and electron microscopy study","volume":"96","author":"Fulton","year":"1978","journal-title":"Arch. Ophthalmol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/archopht.1996.01100130605021","article-title":"Histology of fetal eyes with oculocutaneous albinism","volume":"114","author":"Akeo","year":"1996","journal-title":"Arch. Ophthalmol."},{"key":"ref_87","unstructured":"Federico, J.R., and Krishnamurthy, K. (2024, November 27). Albinism, StatPearls [Internet], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK519018."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/13816810.2016.1266667","article-title":"The clinical evaluation of infantile nystagmus: What to do first and why","volume":"38","author":"Bertsch","year":"2017","journal-title":"Ophthalmic Genet."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/jmg.2004.020040","article-title":"A new phenotype of recessively inherited foveal hypoplasia and anterior segment dysgenesis maps to a locus on chromosome 16q23.2-24.2","volume":"41","author":"Pal","year":"2004","journal-title":"J. Med. Genet."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/13816810.2021.1888128","article-title":"Genetic causes of nystagmus, foveal hypoplasia and subnormal visual acuity- other than albinism","volume":"42","author":"Ehrenberg","year":"2021","journal-title":"Ophthalmic Genet."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/S0161-6420(89)32662-5","article-title":"Electroretinographic findings in human oculocutaneous albinism","volume":"96","author":"Wack","year":"1989","journal-title":"Ophthalmology"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10633-019-09692-9","article-title":"Correlation between electroretinography, foveal anatomy and visual acuity in albinism","volume":"139","author":"Hu","year":"2019","journal-title":"Doc. Ophthalmol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"101091","DOI":"10.1016\/j.preteyeres.2022.101091","article-title":"The retinal pigmentation pathway in human albinism: Not so black and white","volume":"91","author":"Bakker","year":"2022","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e124387","DOI":"10.1172\/jci.insight.124387","article-title":"One-year pilot study on the effects of nitisinone on melanin in patients with OCA-1B","volume":"4","author":"Adams","year":"2019","journal-title":"JCI Insight"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/JABB\/2017\/38504","article-title":"Treat Oculocutaneous Albinism with Gene Therapy","volume":"16","author":"Nelwan","year":"2017","journal-title":"J. Adv. Biol. Biotechnol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/bjo.79.7.697","article-title":"X linked retinoschisis","volume":"79","author":"George","year":"1995","journal-title":"Br. J. Ophthalmol."},{"key":"ref_97","first-page":"836","article-title":"X-linked retinal disorders and the Lyon hypothesis","volume":"104","author":"Jay","year":"1985","journal-title":"Trans. Ophthalmol. Soc. UK"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"9250","DOI":"10.1167\/iovs.11-8115","article-title":"X-linked retinoschisis: RS1 mutation severity and age affect the ERG phenotype in a cohort of 68 affected male subjects","volume":"52","author":"Bowles","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_99","first-page":"816","article-title":"Expression of X-linked retinoschisis protein RS1 in photoreceptor and bipolar cells","volume":"42","author":"Molday","year":"2001","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1172\/JCI81380","article-title":"Synaptic pathology and therapeutic repair in adult retinoschisis mouse by AAV-RS1 transfer","volume":"125","author":"Ou","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"10721","DOI":"10.1074\/jbc.M413117200","article-title":"RS1, a discoidin domain-containing retinal cell adhesion protein associated with X-linked retinoschisis, exists as a novel disulfide-linked octamer","volume":"280","author":"Wu","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.spen.2017.05.005","article-title":"Juvenile Macular Degenerations","volume":"24","author":"Altschwager","year":"2017","journal-title":"Semin. Pediatr. Neurol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archopht.126.6.807","article-title":"Retinal morphological changes of patients with X-linked retinoschisis evaluated by Fourier-domain optical coherence tomography","volume":"126","author":"Gerth","year":"2008","journal-title":"Arch. Ophthalmol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1001\/archopht.118.8.1098","article-title":"Phenotypic expression of juvenile X-linked retinoschisis in Swedish families with different mutations in the XLRS1 gene","volume":"118","author":"Eksandh","year":"2000","journal-title":"Arch. Ophthalmol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1167\/iovs.07-1071","article-title":"Synaptic pathology in retinoschisis knockout (Rs1-\/y) mouse retina and modification by rAAV-Rs1 gene delivery","volume":"49","author":"Takada","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/A:1002432919073","article-title":"Mutations of the XLRS1 gene cause abnormalities of photoreceptor as well as inner retinal responses of the ERG","volume":"98","author":"Bradshaw","year":"1999","journal-title":"Doc. Ophthalmol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1016\/S0042-6989(01)00188-2","article-title":"Analysis of photoreceptor function and inner retinal activity in juvenile X-linked retinoschisis","volume":"41","author":"Khan","year":"2001","journal-title":"Vision. Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1167\/iovs.19-27897","article-title":"Retinal Function in X-Linked Juvenile Retinoschisis","volume":"60","author":"Ambrosio","year":"2019","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1364\/JOSAA.29.002598","article-title":"Multimodal adaptive optics retinal imager: Design and performance","volume":"29","author":"Hammer","year":"2012","journal-title":"J. Opt. Soc. Am. A Opt. Image Sci. Vis."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"108344","DOI":"10.1016\/j.exer.2020.108344","article-title":"Carbonic anhydrase inhibition in X-linked retinoschisis: An eye on the photoreceptors","volume":"202","author":"Ambrosio","year":"2021","journal-title":"Exp. Eye Res."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Fenner, B.J., Russell, J.F., Drack, A.V., Dumitrescu, A.V., Sohn, E.H., Russell, S.R., Boldt, H.C., Affatigato, L.M., Hoffmann, J.M., and Andorf, J.L. (2023). Long-term functional and structural outcomes in X-linked retinoschisis: Implications for clinical trials. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1204095"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/0-387-32442-9_39","article-title":"Disease mechanisms and gene therapy in a mouse model for X-linked retinoschisis","volume":"572","author":"Molday","year":"2006","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"6222","DOI":"10.1073\/pnas.092528599","article-title":"Inactivation of the murine X-linked juvenile retinoschisis gene, Rs1h, suggests a role of retinoschisin in retinal cell layer organization and synaptic structure","volume":"99","author":"Weber","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.ymthe.2018.05.025","article-title":"Retinal AAV8-RS1 Gene Therapy for X-Linked Retinoschisis: Initial Findings from a Phase I\/IIa Trial by Intravitreal Delivery","volume":"26","author":"Cukras","year":"2018","journal-title":"Mol. Ther."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.oret.2022.06.013","article-title":"Intravitreal Delivery of rAAV2tYF-CB-hRS1 Vector for Gene Augmentation Therapy in Patients with X-Linked Retinoschisis: 1-Year Clinical Results","volume":"6","author":"Pennesi","year":"2022","journal-title":"Ophthalmol. Retina"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.1093\/hmg\/ddt329","article-title":"Molecular modeling indicates distinct classes of missense variants with mild and severe XLRS phenotypes","volume":"22","author":"Sergeev","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"107827","DOI":"10.1016\/j.exer.2019.107827","article-title":"Extracting the ON and OFF contributions to the full-field photopic flash electroretinogram using summed growth curves","volume":"189","author":"Akula","year":"2019","journal-title":"Exp. Eye Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10633-016-9534-1","article-title":"Differentiation of murine models of \u201cnegative ERG\u201d by single and repetitive light stimuli","volume":"132","author":"Tanimoto","year":"2016","journal-title":"Doc. Ophthalmol."},{"key":"ref_119","first-page":"5941","article-title":"Prospective Evaluation of Patients With X-Linked Retinoschisis during 18 Months","volume":"59","author":"Pennesi","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1113\/jphysiol.2011.220152","article-title":"Lactate flux in astrocytes is enhanced by a non-catalytic action of carbonic anhydrase II","volume":"590","author":"Stridh","year":"2012","journal-title":"J. Physiol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/13816810.2019.1616303","article-title":"Carbonic anhydrase inhibitors in patients with X-linked retinoschisis: Effects on macular morphology and function","volume":"40","author":"Testa","year":"2019","journal-title":"Ophthalmic Genet."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/IAE.0b013e3181e587f9","article-title":"The use of carbonic anhydrase inhibitors in the retreatment of cystic macular lesions in retinitis pigmentosa and X-linked retinoschisis","volume":"31","author":"Thobani","year":"2011","journal-title":"Retina"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1023\/A:1002143802926","article-title":"The role of carbonic anhydrase inhibitors in the management of macular edema","volume":"97","author":"Wolfensberger","year":"1999","journal-title":"Doc. Ophthalmol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archopht.1990.01070130026013","article-title":"Hypothesis concerning carbonic anhydrase treatment of cystoid macular edema: Example with epiretinal membrane","volume":"108","author":"Marmor","year":"1990","journal-title":"Arch. Ophthalmol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1167\/iovs.16-20078","article-title":"Carbonic Anhydrase Inhibitors for the Treatment of Cystic Macular Lesions in Children With X-Linked Juvenile Retinoschisis","volume":"57","author":"Verbakel","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/2\/614\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:31:27Z","timestamp":1759919487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/2\/614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,18]]},"references-count":125,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["jcm14020614"],"URL":"https:\/\/doi.org\/10.3390\/jcm14020614","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,18]]}}}